摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

2-乙基-6-甲基苯肼 | 74404-34-5

中文名称
2-乙基-6-甲基苯肼
中文别名
——
英文名称
2-ethyl-6-methylphenylhydrazine
英文别名
(2-Ethyl-6-methylphenyl)hydrazine
2-乙基-6-甲基苯肼化学式
CAS
74404-34-5
化学式
C9H14N2
mdl
MFCD02646642
分子量
150.224
InChiKey
RNOZNCRHRYXBTD-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    2.3
  • 重原子数:
    11
  • 可旋转键数:
    2
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.333
  • 拓扑面积:
    38
  • 氢给体数:
    2
  • 氢受体数:
    2

SDS

SDS:9d6873304af7e03f9399d2182470eb3d
查看

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    2-乙基-6-甲基苯肼氢氧化钾ammonium hydroxide 作用下, 反应 28.0h, 生成 N-(2-ethyl-6-methylphenylamino)-S-allyl-S-(5-methoxycarbonyl-2-furfuryl)imidodithiocarbonate
    参考文献:
    名称:
    Syntheses Starting from 2,6-Dialkylphenylhydrazines
    摘要:
    1,4-二取代半胱氨酸酰胺 I,二硫代卡巴酯 II,III 和 N-(2,6-二烷基苯胺基)咪唑硫代碳酸酯酯 IV,V 是由2,6-二烷基苯基肼制备的。 产品经过农药活性测试。
    DOI:
    10.1135/cccc19921699
  • 作为产物:
    描述:
    2-甲基-6-乙基苯胺sodium hydroxide 作用下, 以 为溶剂, 生成 2-乙基-6-甲基苯肼
    参考文献:
    名称:
    "1,4" Alkyl migrations in Fischer indole cyclizations
    摘要:
    DOI:
    10.1021/ja00534a033
点击查看最新优质反应信息

文献信息

  • 5-Aryl-2-furancarbaldehyde Hydrazones and Related Compounds
    作者:Alžbeta Krutošíková、Miloslava Dandárová、Juraj Alföldi
    DOI:10.1135/cccc19931905
    日期:——

    A series of 5-aryl-2-furancarbaldehyde 2,6-dialkylphenylhydrazones (Ia - Iv) and dimethylhydrazones (IIa - IIf) as well as related compound benzo[b]furan-2-carbaldehyde dimethylhydrazone (III) were prepared. Compounds Ia - Iv were synthesized by condensing 5-aryl-2-furancarbaldehydes with 2,6-dialkylphenylhydrazines, compounds IIa - IIf were obtained from the same starting compounds and N,N-dimethylhydrazine. The intermediate 5-aryl-2-furancarbaldehydes were prepared by reaction of aryldiazonium chlorides with 2-furancarbaldehyde. The structure of the compounds were proven by 1H, 13C and 15N NMR spectra.

    一系列5-芳基-2-呋喃甲醛2,6-二烷基苯基腙(Ia - Iv)和二甲基腙(IIa - IIf)以及相关化合物苯并[b]呋喃-2-甲醛二甲基腙(III)已经制备。化合物Ia - Iv通过5-芳基-2-呋喃甲醛与2,6-二烷基苯基腙缩合合成,化合物IIa - IIf则来自相同起始化合物和N,N-二甲基腙。中间体5-芳基-2-呋喃甲醛通过芳基重氮氯化物与2-呋喃甲醛反应制备。这些化合物的结构通过1H、13C和15N核磁共振谱得到证实。
  • Synthesis and Reactions of Furo[3,2-b]pyrrole Type Aldehydes
    作者:Alžbeta Krutošíková、Miloslava Dandárová、Juraj Alföldi
    DOI:10.1135/cccc19932139
    日期:——

    The synthesis of ethyl 2-formyl-4-benzylfuro[3,2-b]pyrrole-5-carboxylate (I) is described. A series of furo[3,2-b]pyrrole-2-carbaldehyde 2,6-dialkylphenylhydrazones (IIa - IIg) and dimethylhydrazones (IIIa - IIId) were prepared. By reaction of title compounds with hydroxylammonium chloride in acetic anhydride in the presence of pyridine corresponding cyano-substituted compounds (IVa - IVd) were obtained. Alkaline hydrolysis of IVa - IVd gave Va - Vb and the reaction with sodium azide and ammonium chloride in dimethylformamide led to VIa - VId. the structure of the compounds have been proved by UV, IR, 1H and 13C NMR spectra.

    描述了乙酸2-甲酰基-4-苄基呋喃[3,2-b]吡咯-5-羧酸乙酯(I)的合成。制备了一系列呋喃[3,2-b]吡咯-2-甲醛2,6-二烷基苯肼酮(IIa - IIg)和二甲基肼酮(IIIa - IIId)。通过将标题化合物与乙酸酐中的羟胺盐和吡啶反应,在生成的氰基取代化合物(IVa - IVd)中。对IVa - IVd进行碱性水解得到Va - Vb,并在二甲基甲酰胺中与叠氮化钠和氯化铵反应得到VIa - VId。这些化合物的结构已通过UV、IR、1H和13C NMR谱证明。
  • CRTH2 Receptor Ligands For Medicinal Uses
    申请人:Ulven Trond
    公开号:US20090099189A1
    公开(公告)日:2009-04-16
    Compounds of formula (I) are useful for the treatment of disease responsive to modulation of CRTH2 receptor activity, such as asthma, rhinitis, allergic airway syndrome, and allergic rhinobronchitis, wherein A represents a carboxyl group —COON, or a carboxyl bioisostere; A 1 , is hydrogen or methyl; ring Ar 1 is an optionally substituted phenyl ring 5- or 6-membered monocyclic heteroaryl ring, in which AA 1 CHO— and L2 are linked to adjacent ring atoms; rings Are 2 , Ar 3 each independently represent a phenyl or 5- or 6-membered monocyclic heteroaryl ring, or a bicyclic ring system consisting of a 5- or 6-membered carbocyclic or heterocyclic ring which is benz-fused or fused to a 5- or 6-membered monocyclic heteroaryl ring, said ring or ring system being optionally substituted; t is 0 or 1; L2 and L3 are linker radicals as defined in the description.
    式(I)的化合物可用于治疗对CRTH2受体活性调节敏感的疾病,例如哮喘、鼻炎、过敏性气道综合症和过敏性鼻支气管炎,其中A代表羧基—COON或羧基生物同位素;A1为氢或甲基;环Ar1是一个可选取代的苯环5-或6-成员的单环杂环,其中AA1CHO—和L2与相邻的环原子连接;环Are2,Ar3各自独立地表示一个苯环或5-或6-成员的单环杂环,或由一个5-或6-成员的碳环或杂环组成的双环系统,该环或环系统被苯并或与一个5-或6-成员的单环杂环融合,该环或环系统是可选取代的;t为0或1;L2和L3是如描述中所定义的连接基团。
  • CRTH2 receptor ligands for medicinal uses
    申请人:Ulven Trond
    公开号:US20110269763A1
    公开(公告)日:2011-11-03
    Compounds of formula (I) are useful for the treatment of disease responsive to modulation of CRTH2 receptor activity, such as asthma, rhinitis, allergic airway syndrome, and allergic rhinobronchitis: wherein A represents a carboxyl group —COOH, or a carboxyl bioisostere; A 1 is hydrogen or methyl; ring Ar 1 is an optionally substituted phenyl ring or 5- or 6-membered monocyclic heteroaryl ring, in which AA 1 CHO— and L2 are linked to adjacent ring atoms; rings Ar 2 , Ar 3 each independently represent a phenyl or 5- or 6-membered monocyclic heteroaryl ring, or a bicyclic ring system consisting of a 5- or 6-membered carbocyclic or heterocyclic ring which is benz-fused or fused to a 5- or 6-membered monocyclic heteroaryl ring, said ring or ring system being optionally substituted; t is 0 or 1; L2 and L3 are linker radicals as defined in the description.
    式(I)的化合物可用于治疗对CRTH2受体活性调节敏感的疾病,例如哮喘、鼻炎、过敏性气道综合症和过敏性鼻支气管炎:其中A代表羧基—COOH或羧基生物同位素;A1为氢或甲基;环Ar1为可选取代的苯环或5-或6-成员的单环杂环,其中AA1CHO—和L2连接到相邻的环原子上;环Ar2、Ar3各自独立地表示苯环或5-或6-成员的单环杂环,或由5-或6-成员的碳环或杂环组成的双环系统,该环或环系统是苯并或与5-或6-成员的单环杂环融合,该环或环系统是可选的取代;t为0或1;L2和L3是如描述中定义的连接基。
  • CRTH2 Receptor Ligands for Medical Use
    申请人:7TM Pharma A/S
    公开号:EP2336113A1
    公开(公告)日:2011-06-22
    4-Bromo-2-[1-(2,6-dichlorophenyl)-1H-pyrazole-4-carbonyl]phenoxyl acetic acid is useful for the treatment of disease responsive to modulation of CRTH2 receptor activity, such as asthma, rhinitis, allergic airway syndrome, and allergic rhinobronchitis.
    4-溴-2-[1-(2,6-二氯苯基)-1H-吡唑-4-甲酰基]苯氧乙酸可用于治疗对调节 CRTH2 受体活性有反应的疾病,如哮喘、鼻炎、过敏性气道综合征和过敏性鼻支气管炎。
查看更多

同类化合物

(βS)-β-氨基-4-(4-羟基苯氧基)-3,5-二碘苯甲丙醇 (S)-(-)-7'-〔4(S)-(苄基)恶唑-2-基]-7-二(3,5-二-叔丁基苯基)膦基-2,2',3,3'-四氢-1,1-螺二氢茚 (S)-盐酸沙丁胺醇 (S)-3-(叔丁基)-4-(2,6-二甲氧基苯基)-2,3-二氢苯并[d][1,3]氧磷杂环戊二烯 (S)-2,2'-双[双(3,5-三氟甲基苯基)膦基]-4,4',6,6'-四甲氧基联苯 (S)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (R)富马酸托特罗定 (R)-(-)-盐酸尼古地平 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[((6-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-3-(叔丁基)-4-(2,6-二苯氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (R)-2-[((二苯基膦基)甲基]吡咯烷 (N-(4-甲氧基苯基)-N-甲基-3-(1-哌啶基)丙-2-烯酰胺) (5-溴-2-羟基苯基)-4-氯苯甲酮 (5-溴-2-氯苯基)(4-羟基苯基)甲酮 (5-氧代-3-苯基-2,5-二氢-1,2,3,4-oxatriazol-3-鎓) (4S,5R)-4-甲基-5-苯基-1,2,3-氧代噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4-溴苯基)-[2-氟-4-[6-[甲基(丙-2-烯基)氨基]己氧基]苯基]甲酮 (4-丁氧基苯甲基)三苯基溴化磷 (3aR,8aR)-(-)-4,4,8,8-四(3,5-二甲基苯基)四氢-2,2-二甲基-6-苯基-1,3-二氧戊环[4,5-e]二恶唑磷 (2Z)-3-[[(4-氯苯基)氨基]-2-氰基丙烯酸乙酯 (2S,3S,5S)-5-(叔丁氧基甲酰氨基)-2-(N-5-噻唑基-甲氧羰基)氨基-1,6-二苯基-3-羟基己烷 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-双(2,6-二甲氧基苯基)-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2S)-(-)-2-{[[[[3,5-双(氟代甲基)苯基]氨基]硫代甲基]氨基}-N-(二苯基甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[[((1R,2R)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2-硝基苯基)磷酸三酰胺 (2,6-二氯苯基)乙酰氯 (2,3-二甲氧基-5-甲基苯基)硼酸 (1S,2S,3S,5S)-5-叠氮基-3-(苯基甲氧基)-2-[(苯基甲氧基)甲基]环戊醇 (1-(4-氟苯基)环丙基)甲胺盐酸盐 (1-(3-溴苯基)环丁基)甲胺盐酸盐 (1-(2-氯苯基)环丁基)甲胺盐酸盐 (1-(2-氟苯基)环丙基)甲胺盐酸盐 (-)-去甲基西布曲明 龙胆酸钠 龙胆酸叔丁酯 龙胆酸 龙胆紫 龙胆紫 齐达帕胺 齐诺康唑 齐洛呋胺 齐墩果-12-烯[2,3-c][1,2,5]恶二唑-28-酸苯甲酯 齐培丙醇 齐咪苯 齐仑太尔 黑染料 黄酮,5-氨基-6-羟基-(5CI) 黄酮,6-氨基-3-羟基-(6CI) 黄蜡,合成物 黄草灵钾盐